Meta-analysis Evaluating the Correlation Between Sleep Paralysis and Clinical Anxiety SymptomsSleep paralysis is linked to higher levels of anxiety

This meta-analysis investigates the clinical relationship between sleep paralysis and anxiety disorders, providing critical data for clinicians managing patients with sleep disturbances. By analyzing a large cohort of 5,568 individuals, the study aimed to quantify the psychological impact of sleep paralysis and determine if it serves as a significant indicator of underlying anxiety pathology.

Primary outcomes focused on anxiety scores, where the data revealed a statistically significant increase in the sleep paralysis group compared to control subjects. The reported standardized mean difference (SMD) of 0.35 (95% CI 0.27-0.44; p < 0.01) confirms that patients experiencing sleep paralysis exhibit higher levels of psychological distress. This suggests that sleep paralysis may be a relevant clinical marker for assessing the severity of anxiety in patients presenting with sleep-related complaints.

Secondary outcomes examined the prevalence of anxiety disorders within the sleep paralysis population. Initial findings showed no statistically significant difference in prevalence between the groups (RR 1.28; 95% CI 0.59-2.77; p = 0.53). However, a sensitivity analysis conducted after removing a single outlier yielded a significant risk of anxiety prevalence (RR 1.80; 95% CI 1.08-2.99). This discrepancy highlights the importance of careful data interpretation when evaluating prevalence in heterogeneous populations.

From a clinical perspective, the findings suggest that while the presence of sleep paralysis does not always guarantee a diagnosis of an anxiety disorder, it is consistently associated with higher subjective anxiety scores. Clinicians should consider the psychological burden of sleep paralysis and its potential role as a symptom of broader anxiety-related conditions. The association may warrant more targeted screening for anxiety in patients reporting frequent episodes of sleep paralysis.

The study's methodology highlights the impact of outliers on prevalence data, which is a critical consideration for evidence-based practice. While the primary outcome of anxiety scores remains robust, the fluctuating significance of prevalence underscores the need for cautious interpretation of meta-analytic data. Clinicians must weigh these findings carefully when determining the necessity of pharmacological or behavioral interventions for sleep-related distress.

In conclusion, the meta-analysis provides evidence that sleep paralysis is linked to elevated anxiety levels. While the study does not establish a causal link, the consistent finding of higher anxiety scores in the sleep paralysis cohort provides a basis for improved patient screening. Clinicians can use these findings to better identify patients who may require integrated treatment for both sleep disturbances and comorbid anxiety symptoms.